BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2011
View Archived Issues
NK-012 shows promising activity in phase II trial in sensitive relapsed SCLC
Read More
MORAb-004 is active in first-in-human study
Read More
Allergan patents novel lysophospholipid S1P1 receptor modulators
Read More
New beta-secretase 2 inhibitors for diabetes patented by Roche
Read More
Novel AMPK activators synthesized
Read More
Compugen validates second candidate based on CD28/B7 costimulatory family
Read More
Randox launches automated H-FABP assay
Read More
SK Chemicals' new 11-beta-HSD1 inhibitor SKI-2852 is active in models of diabetes
Read More
RG-7112 advances through clinical development for cancer
Read More
Preliminary phase I data suggest safety/activity of RO-4987655 in advanced/metastatic solid tumors
Read More
PSN-821 reduces energy intake in patients with obesity and type 2 diabetes
Read More
Novartis patents new cytochrome P450 inhibitors
Read More
Novel arachidonic acid analogues prepared by Cytometix for use as analgesics
Read More
CHMP adopts positive opinion on Buccolam
Read More
Alzheimer's Drug Discovery Foundation supports Axxam research
Read More
Nile Therapeutics advances phase I trial of cenderitide for heart failure
Read More
Amgen obtains positive CHMP opinion on Vectibix after reexamination
Read More
Mimetogen reports promising phase II data on MIM-D3 in dry eye syndrome
Read More
EMA accepts tesamorelin MAA for review
Read More
Immunomedics receives third milestone payment related to veltuzumab development
Read More
Apeiron Biologics enters research alliance for neuroblastoma therapy CH-14.18
Read More
Banzel approved in Canada for seizures associated with Lennox-Gastaut syndrome
Read More
Jevtana/prednisone combination approved in Canada for prostate cancer
Read More
Evotec and Roche collaborate on protein-activity based biomarkers for use in oncology
Read More
ERYtech completes enrollment in phase I Graspa trial in pancreatic cancer
Read More
